HLA-B and spondyloarthropathy: Considering the marked differences in the peptide-binding patterns of HLA-B*27 compared to the other risk alleles identified in this study, it is highly likely that distinct pathogenic mechanisms are involved in HLA-B*27-associated versus B*27-negative spondyloarthritis.